Cost-Effectiveness of Duloxetine: The Stress Urinary Incontinence Treatment (SUIT) Study

Author： Mihaylova Borislava Pitman Richard Tincello Douglas van der Vaart Huub Tunn Ralf Timlin Louise Quail Deborah Johns Adam Sculpher Mark

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.5, 2010-08, pp. : 565-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Duloxetine: In Stress Urinary Incontinence

By Paul L. McCormack Gillian M. Keating

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2567-2573

Adis International

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

Cost of Stress Urinary Incontinence: A Claims Data Analysis

By Birnbaum H.G.

PharmacoEconomics, Vol. 22, Iss. 2, 2004-01 ,pp. : 95-105

Adis International

Access to resources Recommend Favorite

Treatment of Stress Urinary Incontinence with Non-Animal Stabilised Hyaluronic Acid/Dextranomer (NASHA/Dx) Gel: An Analysis of Utility and Cost

By Kobelt Gisela

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 583-591

Adis International

Access to resources Recommend Favorite

Older pharmacological therapies for stress urinary incontinence are often unreliable, but duloxetine is a promising new option

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 6, 2005-06 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite